Nosa Med AB (ST:NOSA) — Market Cap & Net Worth
Market Cap & Net Worth: Nosa Med AB (NOSA)
Nosa Med AB (ST:NOSA) has a market capitalization of $17.28 Million (Skr160.53 Million) as of May 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #25468 globally and #526 in its home market, demonstrating a 4.58% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nosa Med AB's stock price Skr0.62 by its total outstanding shares 260172581 (260.17 Million). Analyse NOSA cash generation efficiency to see how efficiently the company converts income to cash.
Nosa Med AB Market Cap History: 2016 to 2026
Nosa Med AB's market capitalization history from 2016 to 2026. Data shows change from $618.30 Million to $17.28 Million (-29.74% CAGR).
Index Memberships
Nosa Med AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$14.99 Billion | 0.12% | #126 of 281 |
Weight: Nosa Med AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Nosa Med AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nosa Med AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.62x
Nosa Med AB's market cap is 1.62 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $688.74 Million | $248.00K | -$24.89 Million | 2777.16x | N/A |
| 2018 | $474.81 Million | $5.25 Million | -$42.02 Million | 90.35x | N/A |
| 2019 | $370.46 Million | $1.94 Million | -$73.76 Million | 191.35x | N/A |
| 2020 | $105.29 Million | $1.37 Million | -$229.12 Million | 77.02x | N/A |
| 2021 | $63.73 Million | $5.85 Million | -$58.56 Million | 10.89x | N/A |
| 2022 | $8.40 Million | $6.85 Million | -$17.82 Million | 1.23x | N/A |
| 2023 | $22.20 Million | $10.39 Million | -$46.55 Million | 2.14x | N/A |
| 2024 | $26.04 Million | $16.10 Million | -$10.16 Million | 1.62x | N/A |
Competitor Companies of NOSA by Market Capitalization
Companies near Nosa Med AB in the global market cap rankings as of May 4, 2026.
Key companies related to Nosa Med AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Nosa Med AB Historical Marketcap From 2016 to 2026
Between 2016 and today, Nosa Med AB's market cap moved from $618.30 Million to $ 17.28 Million, with a yearly change of -29.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr17.28 Million | +1.65% |
| 2025 | Skr17.00 Million | -34.73% |
| 2024 | Skr26.04 Million | +17.28% |
| 2023 | Skr22.20 Million | +164.33% |
| 2022 | Skr8.40 Million | -86.82% |
| 2021 | Skr63.73 Million | -39.47% |
| 2020 | Skr105.29 Million | -71.58% |
| 2019 | Skr370.46 Million | -21.98% |
| 2018 | Skr474.81 Million | -31.06% |
| 2017 | Skr688.74 Million | +11.39% |
| 2016 | Skr618.30 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Nosa Med AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.28 Million USD |
| MoneyControl | $17.28 Million USD |
| MarketWatch | $17.28 Million USD |
| marketcap.company | $17.28 Million USD |
| Reuters | $17.28 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nosa Med AB
Nosa Plugs AB, a medical technology company, develops, manufactures, and sells intranasal breathing products in Sweden, rest of Europe, the United States, Canada, and internationally. The company offers NOSA allergy filter that filters airborne allergens, such as pollen, pet dander, dust, and mold; NOSA smell training, a smell training medical device to improve the sense of smell for individuals … Read more